Background The prescription of antidepressant drugs during pregnancy has been steadily
increasing for several decades. Meta-analyses (MAs), which increase the statistical power …

Statement of Retraction Retraction: Anatomy of a Woebot®(WB001): Agent Guided CBT for
women with postpartum depression We, the Editor and Publisher of Expert Review of …

Importance Antidepressant use during pregnancy has been associated with
neurodevelopmental disorders in children in some studies. However, results may be …

Abstract Purpose of Review To provide an updated summary and appraisal of work from
2019 to 2022 examining risks of selective serotonin reuptake inhibitor (SSRI) use in …

The global spread of the novel coronavirus severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) and the continuously emerging new variants underscore an urgent need for …

Objective Antidepressant medications are used by increasing numbers of pregnant women.
The evidence on the relationship between antidepressant use during pregnancy and the risk …

Objective Major depressive disorder (MDD) and anxiety disorders are both common and
especially challenging during pregnancy. Considering possible risks of intrauterine drug …

Gestational stress can increase postpartum depression in women. To treat maternal
depression, fluoxetine (FLX) is most commonly prescribed. While FLX may be effective for …

Importance Concerns exist about long-term neurodevelopmental consequences of prenatal
exposure to antidepressants. Objective To evaluate whether maternal prescription fill for …

Purpose Sertraline, a selective serotonin reuptake inhibitor (SSRI), is one of the most
commonly used antidepressant during pregnancy. Plasma sertraline concentrations vary …